Blueberries Medical Corp. BBRRF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -36.22% | -31.10% | -34.50% | 51.18% | 47.58% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -36.22% | -31.10% | -34.50% | 51.18% | 47.58% |
| Cost of Revenue | -52.21% | -45.45% | -47.07% | 90.98% | 36.01% |
| Gross Profit | -12.62% | -7.59% | -11.23% | 11.31% | 68.39% |
| SG&A Expenses | -39.40% | -41.68% | 42.50% | 17.42% | 19.45% |
| Depreciation & Amortization | -50.74% | -28.97% | -8.46% | -12.64% | -45.98% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -41.92% | -41.51% | 18.93% | 22.03% | 13.53% |
| Operating Income | 43.75% | 44.72% | -46.26% | -15.13% | -5.65% |
| Income Before Tax | 29.34% | 35.61% | -41.33% | -31.25% | -14.90% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 29.34% | 35.61% | -41.33% | -31.25% | -14.90% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 29.34% | 35.61% | -41.33% | -31.25% | -14.90% |
| EBIT | 43.75% | 44.72% | -46.26% | -15.13% | -5.65% |
| EBITDA | 43.18% | 45.99% | -53.35% | -18.00% | -14.54% |
| EPS Basic | 42.31% | 48.28% | -23.81% | 3.70% | 25.71% |
| Normalized Basic EPS | 42.86% | 50.00% | -27.27% | -7.69% | 22.22% |
| EPS Diluted | 42.31% | 48.28% | -23.81% | 3.70% | 25.71% |
| Normalized Diluted EPS | 42.86% | 50.00% | -27.27% | -7.69% | 22.22% |
| Average Basic Shares Outstanding | 19.26% | 26.41% | 21.30% | 26.44% | 37.13% |
| Average Diluted Shares Outstanding | 19.26% | 26.41% | 21.30% | 26.44% | 37.13% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |